Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Introductory guidance on choosing long-term holds for beginners, focusing on fundamentals, liquidity, and project viability.
27,784 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Arkansas enacted another round of income tax reductions during a special session, continuing a multi-year reform push...
Trump declares the U.S.-Iran peace deal complete, sending stock futures higher and oil prices fluctuating. Yet analys...
When a crypto-focused firm makes a substantial equity bet in a media company, it can signal strategic confidence—and ...
The S&P 500 trades at 22x forward earnings, but a deeper look at cash flow reveals a 32x multiple, driven by AI-relat...
Vitalik Buterin has surpassed his 16,384 ETH selling target, lifting total disposals beyond 18,000 ETH and valued at ...
A new Colorado bill could tax income that doesn't really exist by altering how the AMT and net operating losses are t...
A political clash at the Milan Cortina Games after Trump described a U.S. Olympian as a 'real Loser' has ignited a de...
The Trump Coin Club launches a high-profile World Cup final giveaway tied to top token holders as the asset remains u...
XRP's price fell in the first quarter, but XRP Ledger usage climbed sharply as stablecoins and tokenized assets expan...
SpaceX stock rose again Monday after Elon Musk signaled a possible $1 trillion in annual revenue by 2030, fueling a b...
A year after taking the helm at Stellantis, Antonio Filosa faces a mixed bag: a Q1 2026 earnings beat, a historic 202...